February 28, 2018 / 1:10 PM / 9 months ago

BRIEF-Convert Pharmaceuticals Secures EUR 13.6 Million To Develop Anti-cancer Drugs

Feb 28 (Reuters) - Convert Pharmaceuticals:

* CONVERT PHARMACEUTICALS SAYS GRANTED EUR 13.6 MILLION IN EQUITY AND NON-DILUTIVE FUNDING BY INVESTORS DROIA ONCOLOGY VENTURES, MEUSINVEST AND SPINVENTURE Source text for Eikon: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below